INTRODUCTION
MicroRNAs (miRNAs) are an abundant class of small noncoding RNAs that regulate gene expression at the levels of mRNA stability and translation (Pillai et al., 2005; Eulalio et al., 2008; Guo et al., 2010) . They pair to target sites (referred to as miRNA response elements [MREs] ) within mRNAs to direct the posttranscriptional downregulation of these mRNA targets. The human genome has more than 500 miRNA genes, and miRNAs from individual gene families are able to target hundreds of different messenger RNAs (Baek et al., 2008; Friedman et al., 2009) . Given that more than half of all human mRNAs are estimated to be conserved miRNA targets, miRNAs are thought to have widespread effects on gene regulation (Friedman et al., 2009) . Even though many miRNA knockout models show no apparent defect under normal conditions, they frequently exhibit miRNA-dependent phenotypes when specific stresses are applied (Li et al., 2009; Brenner et al., 2010) . Therefore, miRNAs are proposed to be critical regulators in stress signal mediation and modulation, where inadequate miRNA levels and responses can cause or exacerbate disease (Mendell and Olson, 2012) .
Highly expressed site-containing RNAs, either found naturally or delivered as research reagents, can act as ''sponges'' to titrate miRNAs away from other normal targets (Ebert et al., 2007; Franco-Zorrilla et al., 2007; Mukherji et al., 2011; Hansen et al., 2013; Memczak et al., 2013) . Theoretical and experimental reports have claimed that crosstalk between site-containing RNAs extends far beyond a few highly expressed sponges. Analyses of high-throughput data sets indicate that the activity of a miRNA is not just dependent on its levels but also its relative target site abundance (TA), defined as the relative number of sites within the transcriptome for that miRNA (Arvey et al., 2010; Garcia et al., 2011) . One hypothesis suggests that this crosstalk has a widespread regulatory function, with the act of titrating miRNAs away from their other targets somehow explaining why so many target sites have been conserved in evolution (Seitz, 2009 ). This idea is extended to the notion that many miRNA targets act as competitive endogenous RNAs (ceRNAs) that modulate the repression of other targets as their expression increases or decreases Tay et al., 2011) . Experimental evidence for such a ceRNA crosstalk was initially described for the tumor-suppressor gene PTEN, which appears to be regulated by the abundance of its pseudogene (PTENP1) in a DICER-dependent manner (Poliseno et al., 2010) . Recent studies have reported the potential physiological relevance of other ceRNAs, including a long noncoding RNA that regulates muscle differentiation (Cesana et al., 2011) , an overexpressed 3 0 untranslated region (3 0 UTR) inducing cancer in transgenic mice (Fang et al., 2013) , and a circular RNA (circRNAs) regulating miR-7 activity in the CNS (Hansen et al., 2013; Memczak et al., 2013) . However, such studies have used cancer cell lines with abnormal miRNA and ceRNA expression (Poliseno et al., 2010; Karreth et al., 2011) , leaving their physiological relevance in primary cells unclear.
The ceRNA hypothesis is controversial because it is difficult to imagine how the change in expression of individual miRNA targets, which each typically contribute a miniscule fraction of the TA, could possibly influence enough miRNA molecules to affect regulation of other targets. Consideration of the ceRNA hypothesis would clearly benefit from quantitative knowledge of the intracellular relationship of miRNAs and their corresponding target sites. Although some attempts have been undertaken to evaluate this relationship, the data were typically acquired in silico (Ala et al., 2013; Figliuzzi et al., 2013) , in vitro with purified components (Wee et al., 2012) , or in experimental setups in which rapidly dividing cells were transfected with synthetic miRNAs, which complicate any interpretations more quantitative than relative comparisons (Arvey et al., 2010; Garcia et al., 2011; Tay et al., 2011) . A more recent study not subject to these limitations reported that miRNA efficacy tended to be higher for miRNAs with lower predicted target:miRNA ratios but did not address the question of how much change in ceRNA might be required to detectably influence miRNA efficacy (Mullokandov et al., 2012) .
In this study, we analyzed the stoichiometric relationship of miR-122 and its target sites by manipulating TA through controlled expression of a validated target of miR-122 in primary hepatocytes and livers. miR-122 has been linked to important human diseases, such as hepatitis C, liver cancer, and hypercholesterolemia, and its target genes have been well characterized (Jopling et al., 2005; Krü tzfeldt et al., 2005; Esau et al., 2006; Tsai et al., 2009) . Our absolute quantification of relevant entities in primary cells and disease states provided insights on the relationship between miR-122 TA and miR-122 activity. These results will facilitate future studies predicting the biologically relevant range of TAs of other miRNAs and the magnitude of change in target abundance required to influence gene expression through a ceRNA mechanism.
RESULTS miRNA Target Derepression Is Detected at a High Threshold of Added MREs
To assess the relationship between a miRNA and its MREs and the effect of this relationship on target gene regulation, we chose the highly expressed liver-specific miR-122 as a model system. We manipulated endogenous MREs in a controlled manner by overexpressing a full-length AldolaseA (AldoA) mRNA, a strong and validated target of miR-122 (Krü tzfeldt et al., 2005) , using recombinant adenoviruses (Ad-AldoA) carrying either a mutated (Mut), one (1s), or three (3s) miR-122 binding site(s) (Figures 1A and S1A) . To eliminate potential off-target effects mediated by the AldoA protein, we introduced a premature stop codon that prevented translation of AldoA protein ( Figure S1B ).
To assess the stoichiometric relationship of miR-122 and the added MREs in primary hepatocytes, we measured the absolute number of these entities per cell. Quantitative RT-PCR measurements calibrated with an internal standard curve of synthetic miRNA revealed that miR-122 was expressed at 1.2 3 10 5 molecules per cell ( Figure 1B ), which was comparable to levels previously reported (Bissels et al., 2009) . As expected, miR-16 and miR-33 were each expressed at fewer copies per cell (1.1 3 10 4 and 1.2 3 10 3 , respectively). Next, we measured the increased miR-122 target abundance after infecting hepatocytes with AdAldoA at three different multiplicities of infection (MOI; 2, 20, and 200) with our constructs that introduced zero, one, or three miR-122 MREs per AldoA transcript. Adenovirus constructs showed very high transduction efficiencies ( Figure S2A ), and a linear correlation was observed between viral dose and green fluorescent protein (GFP) mRNA, which was expressed from an independent promoter in the Ad-AldoA vector ( Figure 1C ). Similar results were observed when monitoring GFP protein levels ( Figures S2B and S2C) . At MOI 200, AldoA transcripts increased from 3.3 3 10 3 (endogenous levels) to 0.8-1.1 3 10 6 molecules per cell ( Figure 1D ), introducing up to 2.6 3 10 6 AldoA
MREs per cell ( Figure 1E ). The ratio of AldoA to GFP mRNA showed that the AldoA transcripts were repressed in an MREdependent manner at MOI 2 and 20, which confirmed that miR-122 was functionally engaging the MREs within these transcripts ( Figure 1F ). This regulation disappeared at MOI 200, suggesting that, at this very high MOI, AldoA transcript overwhelmed the regulatory capacity of miR-122 ( Figure 1F ). Quantification of miR-122 confirmed that the loss of regulation was not due to a loss in miR-122; even at very high levels, Ad-AldoA did not influence the levels of either miR-122 or two control miRNAs, although it did reduce miR-33 by 2-fold ( Figure 1G ).
Having observed a loss in AldoA repression at a high MOI, we reasoned that high levels of AldoA transcript could act as a sponge to also derepress cellular miR-122 targets. Indeed, known miR-122 targets, but not a control transcript ApoM, increased at a high MOI ( Figures 1H and S2D ). Interestingly, this derepression was confidently detected only when AldoA MREs exceeded 1.5-2.7 3 10 5 per cell. This threshold corresponded to 1.25-2.25 MREs per miR-122 molecule. Once this threshold was exceeded, additional AldoA MREs led to greater miR-122 target derepression, and the magnitude correlated with the number of miR-122 sites introduced by AldoA transcripts. Altogether, these data demonstrate that derepression mediated through increased expression of a miR-122 target can occur but can be detected only after exceeding a high threshold of added MREs.
The High Threshold Persists after Lowering miR-122 Activity Two scenarios might explain the high threshold of added MREs required to observe endogenous target derepression. The ''excess miRNA'' scenario posits that very abundant miRNAs are present in excess over their targets, and thus competing MREs would need to titrate this excess binding capacity before they could exert an observable effect on endogenous target repression. Our case of miR-122 in hepatocytes would be one of the more attractive candidates for this scenario, given that miR-122 is the most abundant miRNA in hepatocytes (Landgraf et al., 2007) . Indeed, its abundance of 1.2 3 10 5 molecules per cell is among the highest reported for a miRNA in any mammalian system. The second scenario is the ''high TA'' scenario. In this scenario, the effective number of miRNA binding sites within cellular transcripts is so high that even highly expressed miRNAs are mostly bound to a site at any moment in time, and thus the number of competing MREs would need to approach this high effective number of sites before the competing MREs could exert an observable impact on endogenous target repression. The idea of many miRNA binding sites within cellular transcripts is supported by reports that many miRNAs have hundreds of conserved MREs (Friedman et al., 2009) , miRNAs also repress many additional mRNAs with nonconserved MREs (Farh et al., 2005; Krü tzfeldt et al., 2005; Giraldez et al., 2006; Baek et al., 2008) , and high-throughput crosslinking identifies many additional binding sites that would not be classified as MREs because they don't mediate detectable repression (including many sites within open reading frames and marginally effective sites elsewhere) but would nonetheless add to the effective number of binding sites (Hafner et al., 2010) . These two scenarios predict two very different responses to miRNA reduction. In the excess miRNA scenario, miRNA reduction would lower the excess miRNA capacity and thereby lower the threshold of added MREs required to observe endogenous target derepression. In the high TA scenario, the effective number of sites already exceeds the miRNA abundance, and, more importantly, the threshold relates to the effective number of binding sites and not the number of miRNA molecules. Thus, in this scenario, miRNA reduction would lower the degree to which targets are repressed, but it would not lower the threshold of added MREs required to observe derepression. By analyzing whether a change in miRNA levels influences the threshold for the number of added AldoA MREs needed for derepression, we sought to experimentally evaluate which scenario applies. We injected three different amounts (low, intermediate, and high) of Antagomir-122 (Ant-122) into mice and found that miR-122 levels detected in the primary hepatocytes were reduced to 0.3, 0.08, and 0.01 of that observed in hepatocytes from mice injected with the mismatch Ant-122 control (Ant122mm; Figure 2A ) (Krü tzfeldt et al., 2005) . Target gene derepression correlated with decreased miR-122 levels, which confirmed that our miR-122 quantification reflected miR-122 activity ( Figure 2B ). Next, we studied the effect of controlled overexpression of AldoA MRE on target gene derepression in hepatocytes with a modest 3-fold decrease in miR-122 levels. Interestingly, derepression was detected only when exceeding the threshold of 2 3 10 5 AldoA MREs per cell ( Figure 2C ). This Absolute miRNA copy numbers were calculated by multiplying relative abundance (miRNA/snoRNA202) that were normalized to Ant-122mm with the copy number evaluated in Figure 1B . Data represent mean ± SEM (n = 4) for all panels.
threshold was comparable to that observed in cells without reduced miR-122 levels, which indicated that the reason for the threshold was not excess miR-122 binding capacity. Instead, high TA is the more likely reason that the amount of added MREs must exceed a very high level before exerting an observable effect. Some studies claiming ceRNA-mediated gene regulation focus on the number of sites to miRNA families that are shared between the ceRNAs without differentiating between those miRNAs that are expressed at a level sufficient to repress target genes and those that are not (Jeyapalan et al., 2011; Fang et al., 2013) . To demonstrate that derepression can only occur in conditions in which target gene repression is happening, we infected hepatocytes harboring different miR-122 levels with Ad-AldoA at MOI 200 and measured target derepression. Levels of AldoA and respective AldoA MRE copy number per cell were comparable in all Ant-treated samples ( Figures 2D and 2E ). miR-122 target gene derepression was between 1.5-and 2.5-fold in hepatocytes with high miR-122 levels and below 1.5-fold in cells with intermediate miR-122 activity ( Figure 2F ). No target gene derepression was observed in hepatocytes with the lowest miR-122 levels. Altogether, these data demonstrate that miRNAs need to exceed an expression level sufficient to repress their targets in order for targets to be derepressed in a ceRNA-dependent manner.
The Magnitude of Derepression Correlates with Predicted Site Efficacy and Number of Added
AldoA MREs Previous ceRNA studies have focused on only one or a few targets of a miRNA even though a ceRNA change that influences miRNA activity would be expected to affect more than a few targets. Because any perturbation of a cell might result in spurious expression changes in a few predicted targets, a transcriptomewide analysis examining the preferential effect on predicted targets would more confidently detect the influence of a competing RNA. Therefore, we extended our quantitative analysis to the transcriptome and performed RNA sequencing (RNA-seq) on primary hepatocytes infected with different Ad-AldoA constructs at MOI 2, 20, and 200. Then, we analyzed the relationship between the derepression of predicted targets and their site number, site type (6, 7, and 8 nt sites), site position, and other determinants used by TargetScan to calculate total context+ scores of predicted miRNA targets (Lewis et al., 2005; Grimson et al., 2007; Garcia et al., 2011) . When predicted targets of miR-122, miR-33, miR-16, or abundant miRNA families in liver (either let-7, miR-192, or a combination of the next four most abundant families) were distributed into ten context+ score bins and plotted against their median fold change, the effect of target derepression was evident for predicted targets of miR-122 but not for those of any of the other miRNA families (Figures 3A, S3A, S3B, and Table S1 ). As expected, the extent of target derepression correlated with the magnitude of the context+ score as well as with the number of added AldoA MREs. These correlations were also observed in the fold change distributions of miR-122 predicted targets ( Figure 3B ), and analogous results were obtained when stratifying predicted targets by site type ( Figure S3C ). Regardless of how we grouped the predicted targets, the same threshold of R1.5 3 10 5 added MREs per cell was required in order to observe miR-122 derepression. We also studied target gene derepression in primary hepatocytes treated with Ant-122 or the mismatch control Ant-122mm and found that the strongest predicted targets (e.g., those with a context+ scores below -0.2) were significantly derepressed in the Ant-122-treated conditions ( Figures S3D-S3G and Table S1 ).
Modest Changes in Target Abundance Are Induced by Metabolic Stress and Disease Next, we sought to investigate the quantitative relationship between MREs added upon Ad-AldoA infection and those normally contributed by mRNAs of primary hepatocytes. First, we tested how transcript abundances, measured by RNA-seq in fragments per kilobase of transcript per million fragments mapped (FPKM) correlated with the absolute copy numbers determined by quantitative PCR. To this end, we compared the expression levels of four genes that are differentially expressed in primary hepatocyte and liver samples and found a linear relationship between FPKM and absolute copy numbers over several orders of magnitude ( Figure 4A ), which allowed us to transform RNA-seq data to absolute mRNA copies per cell. Then, we compared how AldoA transcript abundance corresponded to genome mRNA abundance at different MOIs of Ad-AldoA-infected hepatocytes.
The AldoA contribution ranged from 0.3%-0.8% at MOI of 2, 6%-12% at MOI 20, and > 50% of all mRNA at MOI 200 (Figure 4B) . In contrast, the largest endogenous contributor to the transcriptome of primary hepatocytes was Transferrin (Trf), which made up only 1.6% of the mRNA (30,000 molecules per cell). Thus, the level of AldoA at the MOI for which derepression was observed (MOI 20 and 200), was substantially higher than that of transcripts from any single cellular gene.
We also attempted to place the AldoA abundance within the context of the miR-122 TA within the hepatocyte transcriptome. A previous estimate of miRNA TA considers all of the 7 and 8 nt sites for that miRNA within expressed 3 0 UTRs (Garcia et al., 2011) . This TA might over-or underestimate the effective number of binding sites of the transcriptome, depending on the extent to which some of these sites are inaccessible (e.g., because they are occluded by mRNA secondary structure or RNA binding proteins) and the extent to which intracellular binding capacity is augmented by additional sites (e.g., 6 nt sites, other marginal sites, and nonconventional sites as well as sites in ORFs, 5 0 UTRs, or noncoding RNAs), many of which might add to the effective number of binding sites without mediating repression. Despite these uncertainties, relative TA estimates for different miRNAs provide a useful basis for distinguishing the more effective miRNAs from the less effective ones (Garcia et al., 2011) .
Our conclusion that competing MREs begin to exert their effects as they approach the miRNA binding capacity of the transcriptome provided the means to evaluate the relationship between the previous TA estimate and the apparent number of binding sites. When calculated as before (summing 7 and 8 nt sites in transcriptome 3 0 UTRs), the miR-122 TA in hepatocytes at Ad-AldoA MOI 2 was 1.8 3 10 5 sites per cell, which essentially matched the threshold of added MREs required to begin to observe derepression. The addition of 6 nt sites in the analysis increased the number to 4.4 3 10 5 miR-122 sites per cell. Given that this was still below the number of added MREs required to
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Quantitative Evaluation of the ceRNA Hypothesis observe half-maximal derepression, for all additional analyses, we considered this revised TA estimate (all 6, 7, and 8 nt sites within the transcriptome 3 0 UTRs), which we define as the apparent TA (or TA app ), as a conservative estimate of the effective number of miRNA sites.
Next, we calculated how AldoA MREs influenced the miR-122 TA app ( Figure 4C ) and what fraction of the TA app AldoA MREs contributed ( Figure 4D ). Because only very highly expressed genes could reach the levels required to affect TA, we searched for endogenous transcripts that quantitatively contributed the largest percentage to transcriptome TA app . Actinb (Actb), which contributed 5.5% of the TA app , was the largest potential contributor to miR-122 site abundance in primary hepatocytes (Figure 4E) , although this contribution was less than the 30% contribution required for AldoA to detectably modulate miR-122 repression ( Figure 4D ). When using the same approach to estimate TA app for let-7, miR-16, miR-33, miR-192, or each of the next four most abundant miRNA families, the transcript with the largest contribution to any TA app was Albumin (Alb), which contributed $3% of the miR-103 TA app ( Figure 4E ).
As a major metabolic integrator of physiological processes, the liver exhibits profound changes of gene regulation in response to insulin signaling and cholesterol metabolism. To examine whether these changes might affect miRNA TA app , we analyzed two models with severe pathological changes in cholesterol metabolism (LDLR-deficient mice, Ldlr -/-) (Ishibashi et al., 1993) and hepatic steatosis (high-fat diet [HFD] mice; Figures 4F, S4A, and Table S2 ) (Channon and Wilkinson, 1936) . We also examined livers that were perfused in the absence and presence of insulin, representing fasted and fed states, respectively ( Figure S4B and Table S2 ). In all livers studied, Alb and Transthyretin (Ttr) contributed $10%-20% to TA app . The only strong contributor that was differentially regulated in any model was major urinary protein 7 (Mup7), which essentially disappeared (A) Predicted targets of miR-122 (red), miR-16 (blue), miR-33 (orange), let-7 (green), miR-192 (purple), or a combination of the next four most abundant liver miRNA families (black) were grouped into ten bins based on their context+ scores. For each miRNA family, the median log 2 fold change is plotted for the predicted targets in each bin. Medians were normalized to that of the bin with genes without sites. Bins each had at least ten genes; see Figure S3B for group sizes.
(B) Cumulative distributions of mRNA changes for genes with no miR-122 site (black) or predicted target genes with the indicated context+ score bins (color). Number of genes per bin: black, 6,629; green, 1,693; orange, 434; red, 120; purple, 33. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, one-sided KolmogorovSmirnov (K-S) test. See also Figure S3 and Table S1 .
Quantitative Evaluation of the ceRNA Hypothesis in livers of HFD mice, causing its contribution to TA app to decrease from 11.6% in normal livers to 0.01% in HFD livers. Alb, the most highly expressed mRNA and the largest potential contributor of sites for the miR-103 family, had the potential to reduce TA app by a maximum of only 20% when fully silenced. Conversely, a 30% increase in target abundance would require the most abundant liver transcript to increase $2.5-fold.
Because none of the small number of genes that alone could alter TA app in a consequential way appeared to do so, we tested whether a substantial change could be achieved through collective changes of all mRNAs. Evaluation of TA app changes for (E and F) Fractional contribution of the largest potential contributors to transcriptome TA app in primary hepatocytes infected with MOI 2 of Ad-AldoA 1s (E) or in wild-type livers (F) originated from mice either fed normal chow or high-fat diet (HFD). Potential contributors were binned by their context+ scores, and the top potential contributors are plotted within each bin. See also Figure S4 and Table S2 .
(G) Relative target abundance of livers from models of physiological (insulin) or disease/stress states (Ldlr -/-and HFD).
miR-122, the next ten most abundant miRNA families in liver, miR-33, and miR-16 revealed that TA app values for these miRNAs were not altered more than 25% in any physiological or disease model, and most changes were below 10% (Figure 4G ). We also calculated TA app values for the liver samples and primary hepatocytes infected with Ad-AldoA at MOI 20, in which derepression was observed. Transcriptome TA app values ranged between 2.5-7.5 3 10 5 sites per cell in liver models, and between 3.6-13 3 10 5 in primary hepatocytes ( Figure S4C ).
No ceRNA Effect Is Detected In Vivo
To examine the influence of AldoA MREs on target gene derepression and relevant physiological endpoints in vivo, we injected wild-type mice with 3 3 10 9 plaque-forming units of Ad-AldoA and examined livers 5 days postinfection. Virally expressed GFP, and therefore adenovirus expression, was comparable in all conditions ( Figure 5A ). Ad-AldoA increased AldoA transcripts from 2.2 3 10 2 (endogenous levels) to 4.7 3 10 3 copies per cell ( Figure 5B ), introducing between 2.6 3 10 3 and 5.1 3 10 3 miR-122 MREs per cell with Ad-AldoA 1s or 3s, respectively ( Figure 5C ). Overexpression of the Ad-AldoA constructs did not change levels of miR-122 or a control miRNA (Figure 5D ). No derepression of any miR-122 target or control gene (Snrk and Dyrk2) was observed ( Figure 5E ). Furthermore, we did not detect changes in serum cholesterol levels ( Figure 5F ), which decrease upon miR-122 inhibition by Ant-122 (Krü tzfeldt et al., 2005) . As predicted from our studies of primary hepatocytes, these results showed that introduction of 5.1 3 10 3 miR-122
MREs per cell was insufficient to induce either target derepression or downstream physiological responses.
DISCUSSION
Our results support a model in which the changes in ceRNAs must begin to approach the TA of miRNA before they can exert a consequential effect on the repression of targets for that miRNA. For miR-122 in hepatocytes, derepression began to be observed at a threshold of 1.5 3 10 5 added sites per cell, a value exceeding the physiological levels of any endogenous target as well as the aggregate change of all predicted targets in different disease states. Altogether, our data imply that a ceRNA effect mediated through a single miRNA family in a physiological or disease setting of the liver is unlikely. However, we cannot exclude the possibility that unidentified highly abundant and regulated noncoding RNAs (including circRNAs) might substantially contribute to the pool of transcriptome binding sites. In stating that changes in endogenous targets are unlikely to mediate a ceRNA effect that is detectable, we do not mean to imply that there is absolutely no molecular consequence of changing the level of an endogenous target. Large changes in each of several dozen target genes could alter TA by 1% or sometimes more, which would influence the repression of other targets but not to an extent that would be detectable by our methods. For example, an increase in TA by 5% is expected to decrease repression of other targets by approximately 5%, causing a target that was previously repress by 30% to now be repressed by approximately 28.5%-a change too small to be detected and presumably too small to be of biological consequence.
Studying the stoichiometric relationship of an miRNA and its TA and assessing the effect of this relationship on target gene regulation has been challenging. Estimates of TA have proven to be particularly difficult, given that the extent to which ineffective or marginally effective binding sites contribute to TA has been unclear, and no experimentally determined TA values had been obtained. Our experiments indicate that the TA app for miR-122 in the hepatocyte transcriptome is 4.4 3 10 5 sites per cell. Although this estimate corresponds to the number of R6 nt seed-matched sites for miR-122 in the 3 0 UTRs, we do not presume that all UTR sites mediate repression. Indeed, the TA app is expected to exceed the number of miR-122 MREs, given that sites that bind the miRNA too transiently to exert repression (including most sites in ORFs) would nonetheless contribute to TA app .
We qualify our TA estimate as an ''apparent TA'' for two reasons: first, our miR-122 TA app is expected to be a function of the strength of the miR-122 site that was used in its determination. The AldoA site is relatively strong (context+ score of À0.4; Figure 4E ). Had we empirically estimated the TA with a weaker miR-122 site, more of the added sites would have been required to approach half derepression, and thus the TA app value would have been correspondingly higher. Second, the endogenous sites contribute to TA app in proportion to their ability to sequester the miRNA, and thus because many weak sites (ranging from those typically classified as nonspecific sites to those that might be more specific yet nonetheless ineffective or marginally effective) each make partial contributions to the TA app , the actual number of sites that contributed is expected to greatly exceed the TA app . When considering this second point, estimating a TA app is of greater practical value than knowing the total number of endogenous sites that helped sequester the miRNA. Our miR-122 TA app was empirically derived on the premise that using Ad-AldoA to double the effective miR-122 TA and thereby decrease the number of encounters between miR-122 and its endogenous targets by half would lead to a corresponding decrease in endogenous target repression. If the amount of miR-122-mediated repression is not a simple linear function of the number of encounters with its targets, then TA app would need to be corrected accordingly. For other miRNAs, TA app values were estimated starting with the miR-122 TA app and assuming that relative values for different miRNAs would scale in proportion to their numbers of UTR sites-an assumption supported by studies showing that miRNA efficacy negatively correlates with the relative numbers of UTR sites (Arvey et al., 2010; Garcia et al., 2011; Mullokandov et al., 2012) . Despite any uncertainty arising from these simplifying assumptions, our TA app estimates have the unique benefit of being founded on intracellular experimental observations. This experimental grounding produced TA app values much higher than those previously assumed. For example, previous modeling of the quantitative relationships between miRNAs and their targets assumed that a typical miRNA had $500 target sites per cell (Wee et al., 2012) . Modeling based on this low number of targets suggests that for moderately expressed miRNAs, adding only 500 sites through increased ceRNA expression could double the expression of a repressed mRNA, whereas for more highly expressed miRNAs, many more sites would be required to exert an effect (Mullokandov et al., 2012; Wee et al., 2012) . Our results in hepatocytes indicate that TA app values for the eleven most abundant miRNA families ranged from 2.5 3 10 5 to 7.5 3 10 5 sites, about 1,000 times greater than the value previously assumed. This substantially revised estimate of effective TA leads to a different and somewhat simplified picture of the potential for regulation through ceRNAs. In our model, miRNA levels matter only in so much as the miRNA must reach a level sufficient to repress a target mRNA. For any miRNA exceeding this level, the potential for ceRNAs to influence repression is simply a matter of whether the ceRNAs add or subtract enough sites to meaningfully influence the TA app . Because TA app is a function of the number of seed-matched sites in the transcriptome and substantially exceeds the level of even the most highly expressed miRNA, the ceRNA difference required to achieve half-maximal effects is independent of the miRNA level. Thus, our insights and results indicate that repression by even moderately expressed miRNAs would be difficult to detectably change through a ceRNA effect. Under extreme physiological and disease conditions, target abundances were not changed more than 10% for most miRNA families. The maximum change of $25% was observed for the let-7 miRNA family in mice fed an HFD versus a chow diet. Interestingly, in this condition, a single highly expressed gene (Mup7) accounted for $50% of the total decrease in let-7 target abundance. A recent phase I trial for RNAi therapy of Ttr amyloidosis reduced human TTR levels by >80% (Coelho et al., 2013) . Such a strong reduction of the TTR transcript, which contributes $10% of the miR-192 TA app in mouse livers, would account for a decrease in miR-192 target abundance analogous to that observed for Mup7 and let-7 in the HFD versus chow diet, a change not expected to detectably affect miRNA activity.
The conclusion that only large contributors to TA app can detectably influence the miRNA activity agrees with our in vivo experiments; in normal liver, AldoA is expressed at $2.4 3 10 2 copies per cell and is among the thousand most highly expressed genes. Still, a 9-fold increase in transcript levels after Ad-AldoA 3s infection, which added $5 3 10 3 MREs, increased miR-122 TA app by only 2% and therefore imparted no detectable influence on target gene expression. Mup7 and Ttr are among the thirty genes expressed in liver at copy numbers above 10 4 copies per cell, and therefore approaching within an order of magnitude the estimated miRNA TA app values. Hence, only these 30 genes have potential on their own to perceptibly influence a TA app .
Our study focused on miR-122, an unusually highly expressed miRNA. Nonetheless, the same high threshold for detectable target derepression was observed when miR-122 activity was reduced, which indicated that our conclusions apply also to more moderately expressed miRNAs. A study reporting loss of miR-20 repression when adding high levels of target mRNA also observed a threshold at high target expression (Mukherji et al., 2011) . As expected, their threshold disappeared when a miR-20 sponge was used to lower miRNA activity below detection. More interestingly, they found that transfecting an miR-20 mimic increased the threshold for derepression. A possible reason that they observed a change in threshold with a change in miRNA, whereas we did not, is that their miR-20 mimic might have added enough miRNA to exceed the miR-20 TA app of their cells. Another difference between their experiments and ours is that their target contained bulged sites of a type that can induce miRNA degradation (Ameres et al., 2010) , which might produce an apparent shift in the threshold.
Gene expression in the liver is profoundly regulated by circadian and hormonal and nutritional states. Using livers of mice exposed to insulin signaling and to pathological conditions of cholesterol metabolism, we did not observe large changes in target abundance, raising the possibility that our findings can be generalized to other organs and disease states. Nonetheless, during cell differentiation and in the context of malignant transformation, expression of coding and noncoding RNA can change dramatically (Rhodes and Chinnaiyan, 2005; Lujambio and Lowe, 2012) . In such biological settings conditions might arise in which TA app is lower than in physiological settings and/or a single mRNA substantially contributes to target abundance. In principle, such alterations could make the system more amenable to ceRNA-mediated gene regulation.
EXPERIMENTAL PROCEDURES Animal Experiments
Animals were maintained on a 12 hr light/12 hr dark cycle under a controlled environment in a pathogen-free facility at the Institute for Molecular Systems Biology, ETH Zü rich. Mice were administered adenovirus through a single tail-vein injection of 3 3 10 9 plaque-forming units in a final volume of 0.2 ml diluted in PBS and killed 5 days postinjection. Antagomir was administered through tail-vein injections on three consecutive days, and primary hepatocytes were isolated on day four. For high, intermediate, and low miR-122 inhibition, mice received 3 3 80, 40, and 20 mg/kg Ant-122, respectively. Ant-122mm (control) was used at the highest concentration. All animal experiments were approved by the ethics committee of the Kantonale Veterinä ramt Zü rich.
Primary Hepatocytes Isolation and Viral Infections
Primary hepatocytes of 8-to 12-week-old male C57BL/6N mice were isolated on the basis of the method described by . Hepatocytes were counted and plated at 300,000 cells per well in Dulbecco's modified Eagle's medium low-glucose media and adenoviruses were added in Hepatozyme media 4-6 hr after plating and harvested 24 hr postinfection. All cells were incubated at 37 C in a humidified atmosphere containing 5% CO 2 .
Adenoviruses
Recombinant adenoviruses were generated as described in the Supplemental Experimental Procedures. All adenoviruses expressed GFP from an independent promoter. Ad-Ctrl was based on the same vector backbone (including GFP) but lacked the AldoA transgene. (Table S3 ). Relative gene expression was calculated with the ddCT method and mouse 36b4 (Rplp0) for normalization.
Gene Expression Analysis
miRNA Expression Analysis 150 ng of total RNA was reverse-transcribed with the TaqMan MicroRNA Assays and Reverse Transcription Kits (Life Technologies). Quantitative PCR reactions were performed with the LightCycler 480 employing TaqMan Universal PCR Master Mix, No AmpErase UNG (Life Technologies), and TaqMan MicroRNA Assays (Life Technologies). Relative miRNA expression was calculated with the ddCT method and mouse snoRNA202 for normalization.
RNA-Seq
For single-end library construction, total RNA was depleted of rRNA with the Ribo-Zero rRNA Removal Kit (Epicenter). RNA libraries were prepared with the dUTP-based, Illumina-compatible NEXTflex Directional RNA-Seq Kit (Bioo Scientific). For paired-end library construction (performed by BGI), total RNA was enriched for poly(A) mRNA with oligo(dT) beads and treated with buffer in order to yield 200-700 nt fragments. First-strand cDNA was synthesized with random hexamer primers, and second-strand cDNA was synthesized with buffer, dNTPs, RNase H, and DNA polymerase I. cDNA was run on an Agarose gel for suitable fragment size selection followed by a purification, adaptor ligation, and PCR amplification. All libraries (both singleand paired-end) were sequenced with an Illumina HiSeq 2000 sequencing machine.
ACCESSION NUMBERS
The NCBI Gene Expression Omnibus accession number for the data reported in this paper is GSE52801. 7mer-A1, 398; 7mer-m8, 269; 8mer, 110; multiple, 203. *P < 0.05, **P < 0.01, ***P < 0.001, ****, P < 0.0001, one-sided Kolmogorov-Smirnov (K-S) test.
SUPPLEMENTAL INFORMATION
(D) miRNA molecules in primary hepatocytes treated with Ant-122 or Ant-122mm.
Mean ± SEM (n = 3). red, 120; purple, 33. *P < 0.05, **P < 0.01, ***P < 0.001, ****, P <0.0001, one-sided K-S test.
(G) Cumulative distributions of mRNA changes in the hepatocytes of (D) for genes with no miR-122 site (black) or predicted target genes with the indicated sites (color).
Otherwise, as in (C). Mut, 1s, and 3s. Table S1 :
Gene expression levels, fold-changes, and predicted target site efficacy scores (context+ scores) across all hepatocyte RNA-seq samples. Related to Figure 3 and S3). Table S2 : Gene expression levels, fold-changes, and predicted target site efficacy scores (context+ scores) across all liver RNA-seq samples. Related to Figure   4 and S4). 
36B4 f GCCGTGATGCCCAGGGAAGACA

36B4 r CATCTGCTTGGAGCCCACGTTG
AldoA f GCGCTGTGTGCTAAAGATTG
AldoA r AGGCTCCACAATGGGTACAA
GFP f GAAGCGCGATCACATGGT
GFP r CCATGCCGAGAGTGATCC
Gys1 f GGTGTGAGGACGCAGGTAG
Gys1 r GCCAACGCCCAAAATACA
Slc7a1 f ATTTCAGCCGGCCTCCTA
Slc7a1 r TGCCCACAGTGTCCCTTC
P4ha1 f CGTGGGGAGGGTATCAAAAT
P4ha1 r ATGGTAGCGGCAGAACAGTC
Ndrg3 f TCCTGGCCAACAAGAAGC
Ndrg3 r CTCATCCATGGTGGGGTACT
Tmed3 f GGTCACGGCTCTCACTCAG
Tmed3 r TCACAGTCTTCAGAGCCTCGT
Snrk f TGCGGGTCTCTTGCATACT
Snrk r GCCCAGGCTCCATATGTCTA
Dyrk2 f CTACCACTACAGCCCACACG
Dyrk2 r TCTGTCCGTGGCTGTTGA
ApoM f CCCAGACATGAAAACAGACCT
ApoM r GGGTGTGGTGACCGATTG
Crot f AGTGAAGGGCATTGTCCAAC
Crot r TCTTGTGGATATATGTCAATTGTCTG
Chka f AACAGATTTGCTCTTGCCTCTC
Chka r TCAAAGTAGGCCTCGAATCTG
EXTENDED EXPERIMENTAL PROCEDURES Animal Experiments
Animals were maintained on a 12-hour light/dark cycle under a controlled environment in a pathogen-free facility at the Institute for Molecular Systems Biology, ETH Zürich (Switzerland). The Ldlr KO mice were originally obtained from the Jackson Laboratory (B6.129S7-Ldlrtm1Her/J) and backcrossed for >10 generations into a C57Bl/6J background. For the liver insulin perfusion experiments, starved
C57Bl/6J mice were euthanized and the portal vein was canulated. The liver was perfused with oxygenated Krebs-Henseleit buffer with 0 or 20 ng/ml insulin at 37 °C in a single-pass mode with a total flow rate of 1.5 to 2 ml min -1 for 4 hours (Wolfrum et al., 2004) . All animal experiments were approved by the ethics committee of the Kantonale Veterinäramt Zürich.
Primary Hepatocytes Isolation and Viral Infections
Primary hepatocytes were isolated based on the method described by Zhang et al. were incubated at 37°C in a humidified atmosphere containing 5% CO 2 .
RNA Isolation
RNA was extracted using Trizol (Life Technologies) according to the manufacturer's instructions, except for a 30 min isopropanol precipitation at -20°C. RNA integrity was analyzed on an Agilent 2100 Bioanalyzer for all samples that were sequenced.
Cell Number Calculation
By dividing total RNA yield from one 6-well plate well (22 ug RNA) by the cell number obtained from microscopy (300,000 cells per 6-well plate well), one hepatocyte was calculated to yield 73.5 pg RNA.
Gene Expression Analysis
2 ug of total RNA was treated with the DNA-free Kit (Life Technologies) and reversetranscribed using the High Capacity cDNA Reverse Transcription Kit (Life Technologies). Quantitative PCR reactions were performed with the Light Cycler 480
(Roche) employing a 384-well format, gene-specific primer pairs (see Table S3 , 
RNA-seq data analysis
To process RNA-seq data, raw reads were aligned to the latest build of the mouse genome (mm10) using STAR v. 2.3.1n (options --outFilterType BySJout --outFilterMultimapScoreRange 0 --readMatesLengthsIn Equal --outFilterIntronMotifs RemoveNoncanonicalUnannotated --clip3pAdapterSeq TCGTATGCCGTCTTCTGCTTG --outStd SAM) (Dobin et al., 2013) . The option "--clip3pNbases 2" was additionally used for the libraries with the following codes:
ACAGTG-s_6, CAGATC-s_6, CGATGT-s_6, CTTGTA-s_6, GCCAAT-s_6, TGACCA-s_6 due to sequencing errors in the last 2 nucleotides. Pooling all biological replicates of a particular sample, differential expression analysis was performed between two samples of interest using cuffdiff v. 2.1.1 (options --librarytype fr-firststrand -b mm10.fa -u --max-bundle-frags 100000000) (Trapnell et al., 2013) , using mouse transcript models of protein-coding and long noncoding RNA genes annotated in Ensembl release 72. For data analysis, only genes with FPKM above 1.0 were considered. Raw files as well as processed files for gene expression measurements and differential expression analysis are deposited in the GEO (accession ID GSE52801).
Target Abundance Calculation
We fit a linear regression function to transform gene expression measurements (measured in FPKM) from RNA-seq data into absolute copy numbers (as determined by quantitative PCR) ( Figure 4A ). To account for experimental noise in qPCR and RNA-seq measurements, we used the constraints that there be no x or y weighting and that the y intercept equal 0. Copy numbers per cell were determined by multiplying the FPKM with the resulting slope of 3.83. For each miRNA, the copy number of each predicted target gene was weighted by the number of 6-, 7-, and 8-nt 3′UTR binding sites, and these values were summed to yield TA app .
Generation of adenovirus construct
AldolaseA variant 2 (AldoA, NM_007438) was amplified from cDNA with primers P1
and P2 (Table S3) and P8 with two miR-122 binding sites were first denatured at 95°C for 5 minutes, annealed by lowering the temperature from 70°C for 10 minutes followed by 60°C, 50°C, 40°C, and 20°C for 3 minutes each (using a ramping temperature of 0.07°C/s) and phosphorylated using T4 Polynucleotide Kinase (NEB). The linker and pCR2.1 Aldo 1s wt backbone were then ligated at room temperature for 1 hour using T4 DNA Ligase (NEB), transformed in Mach1 cells (Life Technologies), screened for insertion length and then sequenced. The three plasmids (pCR2.1 Aldo Mut wt, 1s wt, and 3s wt) were then re-cloned into pVQAd CMV K-NpA (pVQAd, Viraquest) using the restriction sites BamHI and XhoI (NEB). Finally, a stop codon was introduced at amino acid position ten using QuickChange II Site-Directed Mutagenesis Kit
